Share-based Payment Arrangement, Expense of enGene Holdings Inc. from 31 Oct 2022 to 31 Oct 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
enGene Holdings Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Oct 2022 to 31 Oct 2025.
  • enGene Holdings Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Oct 2025 was $2,606,000, a 57% increase year-over-year.
  • enGene Holdings Inc. Share-based Payment Arrangement, Expense for the twelve months ending 31 Oct 2025 was $9,646,000, a 81% increase year-over-year.
  • enGene Holdings Inc. annual Share-based Payment Arrangement, Expense for 2025 was $9,646,000, a 81% increase from 2024.
  • enGene Holdings Inc. annual Share-based Payment Arrangement, Expense for 2024 was $5,324,000, a 54% increase from 2023.
  • enGene Holdings Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3,450,000, a 2874% increase from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

enGene Holdings Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $9,646,000 $2,606,000 +$950,000 +57% 01 Aug 2025 31 Oct 2025 10-K 22 Dec 2025 2025 FY
Q2 2025 $8,696,000 $2,581,000 +$1,121,000 +77% 01 May 2025 31 Jul 2025 10-Q 11 Sep 2025 2025 Q3
Q1 2025 $7,575,000 $2,650,000 +$733,000 +38% 01 Feb 2025 30 Apr 2025 10-Q 12 Jun 2025 2025 Q2
Q4 2024 $6,842,000 $1,809,000 +$1,518,000 +522% 01 Nov 2024 31 Jan 2025 10-Q 10 Mar 2025 2025 Q1
Q3 2024 $5,324,000 $1,656,000 -$1,698,000 -51% 01 Aug 2024 31 Oct 2024 10-K 22 Dec 2025 2025 FY
Q2 2024 $7,022,000 $1,460,000 +$1,423,000 +3846% 01 May 2024 31 Jul 2024 10-Q 11 Sep 2025 2025 Q3
Q1 2024 $5,599,000 $1,917,000 +$1,878,000 +4815% 01 Feb 2024 30 Apr 2024 10-Q 12 Jun 2025 2025 Q2
Q4 2023 $3,721,000 $291,000 +$271,000 +1355% 01 Nov 2023 31 Jan 2024 10-Q 10 Mar 2025 2025 Q1
Q3 2023 $3,450,000 $3,354,000 01 Aug 2023 31 Oct 2023 10-K 19 Dec 2024 2024 FY
Q2 2023 $37,000 01 May 2023 31 Jul 2023 10-Q 10 Sep 2024 2024 Q3
Q1 2023 $39,000 01 Feb 2023 30 Apr 2023 10-Q 14 Jun 2024 2024 Q2
Q4 2022 $20,000 01 Nov 2022 31 Jan 2023 10-Q 11 Mar 2024 2024 Q1

enGene Holdings Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $9,646,000 +$4,322,000 +81% 01 Nov 2024 31 Oct 2025 10-K 22 Dec 2025 2025 FY
2024 $5,324,000 +$1,874,000 +54% 01 Nov 2023 31 Oct 2024 10-K 22 Dec 2025 2025 FY
2023 $3,450,000 +$3,334,000 +2874% 01 Nov 2022 31 Oct 2023 10-K 19 Dec 2024 2024 FY
2022 $116,000 01 Nov 2021 31 Oct 2022 10-K 29 Jan 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.